Table 2.
Description of HIV-positive children.
| No. | Education | CD4 count | Mother's ART regimen | Days on ART before delivery | Caesarean section | Primipara | Institutional delivery | NBP regimen | Days on NBP | Birth weight (kg) | Gender | Feeding type | VL at birth | VL at 6–8 weeks | Type of HIV transmission | Comments |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Secondary | 774 | AZT + 3TC + EFV |
1 | No | Yes | Yes | AZT | 28 | 2.9 | Female | Formula | Negative | Positive | Delivery | |
| 2 | Secondary | 202 | AZT + 3TC + NVP |
1 | Yes | Yes | Yes | AZT | 28 | 2.07 | Male | Formula | Positive | Positive | IU | |
| 3 | No education | 144 | AZT + 3TC + NVP |
12 | No | Yes | Yes | NVP | 1 | — | Female | Formula | Not done | Not done | IU/delivery | |
| 4 | No education | 359 | AZT + 3TC + NFV |
70 | Yes | Yes | Yes | AZT | 7 | 2.25 | Female | Breast | Not done | Positive | IU/delivery | |
| 5 | No education | 251 | D4T + 3TC + EFV |
71 | No | No | Yes | NVP | 1 | — | Female | Mixed | Not done | Negative | Breastfeeding | Poor adherence |
| 6 | Higher | 306 | AZT + 3TC + NFV |
83 | No | Yes | Yes | AZT | 7 | 2.75 | Female | Formula | Not done | Positive | IU/delivery | |
| 7 | Primary | 410 | AZT + 3TC + NFV |
88 | No | No | Yes | AZT | 7 | 2.1 | Female | Breast | Not done | Negative | Breastfeeding | |
| 8 | Secondary | 402 | AZT + 3TC + NVP |
91 | No | Yes | Yes | AZT | 7 | 2.2 | Female | Breast | Not done | Negative | Breastfeeding | |
| 9 | No education | 273 | AZT + 3TC + NVP |
95 | Yes | No | Yes | AZT | 7 | 3.25 | Female | Mixed | Not done | Negative | Breastfeeding | |
| 10 | Unknown | 299 | AZT + 3TC + NVP |
356 | No | No | No | AZT + 3TC + NVP |
42 | 2 | Female | Formula | Not done | Positive | IU/delivery | Poor adherence |
ART: antiretroviral treatment; NBP: newborn prophylaxis; VL: viral load; AZT: zidovudine; 3TC: lamivudine; NVP: nevirapine; EFV: efavirenz; d4T, stavudine; NFV: nelfinavir; IU: intrauterus.